Award recordCONTRACT

ABBOTT MOLECULAR INC.

PIID 36C24822F0151· VHA· 248-NETWORK CONTRACT OFFICE 8 (36C248)· 6640 · LABORATORY EQUIPMENT AND SUPPLIES· FY2022· $2,956,966 net obligations· UEI NK5QDVJBHMN7· IL

Description

EXERCISE OY

Base award description: INFECTIOUS DISEASE PCR REAGENTS AND CONSUMABLES

First action · last action
2022-03-15 · 2025-10-01
Transactions
10
First transaction's obligation
$547,264
Base + all options value (sum of deltas)
$2,956,966
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D40222
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

Modification chain · 10 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$3,486,211$0Base award · 2022-03-15 · this action $547,264 · running total $547,264Modification P00002 · 2022-09-14 · this action $550,000 · running total $1,097,264Modification P00001 · 2022-10-01 · this action $1,094,525 · running total $2,191,788Modification P00003 · 2023-10-01 · this action $1,094,525 · running total $3,286,313Modification P00004 · 2023-11-27 · this action -$29,449 · running total $3,256,864Modification P00005 · 2024-08-09 · this action -$160,838 · running total $3,096,026Modification P00006 · 2024-10-01 · this action $390,185 · running total $3,486,211Modification P00010 · 2025-03-26 · this action -$163,270 · running total $3,322,941Modification P00012 · 2025-06-10 · this action -$828,982 · running total $2,493,959Modification P00013 · 2025-10-01 · this action $463,007 · running total $2,956,966
  • Base2022-03-15+$547,264= $547,264
  • Mod P000022022-09-14+$550,000= $1,097,264
  • Mod P000012022-10-01+$1,094,525= $2,191,788
  • Mod P000032023-10-01+$1,094,525= $3,286,313
  • Mod P000042023-11-27-$29,449= $3,256,864
  • Mod P000052024-08-09-$160,838= $3,096,026
  • Mod P000062024-10-01+$390,185= $3,486,211
  • Mod P000102025-03-26-$163,270= $3,322,941
  • Mod P000122025-06-10-$828,982= $2,493,959
  • Mod P000132025-10-01+$463,007= $2,956,966
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2022-03-15+$547,264$547,264INFECTIOUS DISEASE PCR REAGENTS AND CONSUMABLES
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2022-09-14+$550,000$1,097,264INFECTIOUS DISEASE PCR REAGENTS AND CONSUMABLES
Mod P00001· EXERCISE AN OPTION2022-10-01+$1,094,525$2,191,788INFECTIOUS DISEASE PCR REAGENTS AND CONSUMABLES
Mod P00003· EXERCISE AN OPTION2023-10-01+$1,094,525$3,286,313INFECTIOUS DISEASE PCR REAGENTS AND CONSUMABLES
Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2023-11-27−$29,449$3,256,864DEOBLIGATION MODIFICATION INFECTIOUS DISEASE PCR REAGENTS AND CONSUMABLES
Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-08-09−$160,838$3,096,026DEOBLIGATION MODIFICATION INFECTIOUS DISEASE PCR REAGENTS AND CONSUMABLES OPTYR 1
Mod P00006· EXERCISE AN OPTION2024-10-01+$390,185$3,486,211OPTION YEAR 3
Mod P00010· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2025-03-26−$163,270$3,322,941OPTION YEAR 3
Mod P00012· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2025-06-10−$828,982$2,493,959DEOBLIGATION OF OY2 EXCESS FUNDS.
Mod P00013· EXERCISE AN OPTION2025-10-01+$463,007$2,956,966EXERCISE OY

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI NK5QDVJBHMN7)

AwardOffice · PSC / listingNet obligationsFY
36C24126N0799241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$658,750FY2026
36C26326P0588NETWORK CONTRACT OFFICE 23 (36C263) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$308,299FY2026
36C24126A0041241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$0FY2026
36C24226N0439242-NETWORK CONTRACT OFFICE 02 (36C242) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$1,481,077FY2026
36C24926N0423249-NETWORK CONTRACT OFFICE 9 (36C249) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$471,122FY2026
36C24626N0476246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$421,178FY2026

Other recipients under 6640 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24826A0029ABBOTT LABORATORIES INC.248-NETWORK CONTRACT OFFICE 8 (36C248)$0FY2026
36C24826N0821ABBOTT LABORATORIES INC.248-NETWORK CONTRACT OFFICE 8 (36C248)$289,849FY2026
36C24826P1068CEPHEID248-NETWORK CONTRACT OFFICE 8 (36C248)$63,150FY2026
36C24826P1104HOLOGIC SALES AND SERVICE, LLC248-NETWORK CONTRACT OFFICE 8 (36C248)$263,800FY2026
36C24826P1126TRILLAMED LLC248-NETWORK CONTRACT OFFICE 8 (36C248)$25,838FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24822F0151_3600_V797D40222_3600 · retrieved 2026-09-26.